Mithra Pharmaceuticals SA (MITRA.BR) Stock Analyst Earnings Estimates
EBR:MITRA - Euronext Brussels - BE0974283153 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 22.668M 151.03% | 66.997M 195.56% | 40.155M -40.06% | 55.723M 38.77% | 84.769M 52.13% | 118.97M 40.35% | |
| EBITDA YoY % growth | -77.449M -4.79% | -14.305M 81.53% | N/A 80.92% | -13.905M -409.43% | 28.995M 308.52% | 69.422M 139.43% | |
| EBIT YoY % growth | -87.875M -5.02% | -26.245M 70.13% | -64.985M -147.61% | -24.36M 62.52% | 19.364M 179.49% | 50.367M 160.11% | |
| Operating Margin | -387.66% | -39.17% | -161.84% | -43.72% | 22.84% | 42.34% | |
| EPS YoY % growth | N/A -129.02% | N/A 12.28% | N/A 25.22% | -0.58 32.90% | 0.21 135.27% | 0.66 220.00% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 40.155M -27.83% | % | ||
| Q2 2023 Q2Q % growth | 7.035M -38.06% | % | ||
| Q4 2022 Q2Q % growth | 55.64M 428.60% | % | ||
| Q2 2022 Q2Q % growth | 11.357M -6.47% | % | ||
| Q4 2021 Q2Q % growth | 10.526M 61.37% | % | ||
| Q2 2021 Q2Q % growth | 12.142M 384.32% | % | ||
| Q4 2020 Q2Q % growth | 6.523M -91.52% | % | ||
| Q2 2020 Q2Q % growth | 2.507M -87.18% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | -5.59% | -122.19% |
| Revenue | N/A | N/A | 0% | 0% |